These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 22980431

  • 1. Misoprostol for the management of postpartum bleeding: a new approach.
    Dabash R, Blum J, Raghavan S, Anger H, Winikoff B.
    Int J Gynaecol Obstet; 2012 Dec; 119(3):210-2. PubMed ID: 22980431
    [Abstract] [Full Text] [Related]

  • 2. A cluster-randomized, non-inferiority trial comparing use of misoprostol for universal prophylaxis vs. secondary prevention of postpartum hemorrhage among community level births in Egypt.
    Anger HA, Dabash R, Hassanein N, Darwish E, Ramadan MC, Nawar M, Charles D, Breebaart M, Winikoff B.
    BMC Pregnancy Childbirth; 2020 May 24; 20(1):317. PubMed ID: 32448257
    [Abstract] [Full Text] [Related]

  • 3. Interpretation of national policy regarding community-based use of misoprostol for postpartum hemorrhage prevention in Ethiopia: a tale of two regions.
    Spangler SA, Gobezayehu AG, Hailemariam TG, Sibley LM.
    J Midwifery Womens Health; 2014 Jan 24; 59 Suppl 1():S83-90. PubMed ID: 24588920
    [Abstract] [Full Text] [Related]

  • 4. Using Misoprostol for Primary versus Secondary Prevention of Postpartum Haemorrhage - Do Costs Matter?
    Chatterjee S, Sarkar A, Rao KD.
    PLoS One; 2016 Jan 24; 11(10):e0164718. PubMed ID: 27755601
    [Abstract] [Full Text] [Related]

  • 5. Misoprostol for prevention and treatment of postpartum hemorrhage: what do we know? What is next?
    Raghavan S, Abbas D, Winikoff B.
    Int J Gynaecol Obstet; 2012 Oct 24; 119 Suppl 1():S35-8. PubMed ID: 22883912
    [Abstract] [Full Text] [Related]

  • 6. Prevention of postpartum hemorrhage with misoprostol.
    International Federation Of Gynecology and Obstetrics.
    Int J Gynaecol Obstet; 2012 Dec 24; 119(3):213-4. PubMed ID: 23022109
    [No Abstract] [Full Text] [Related]

  • 7. Misoprostol for preventing and treating postpartum hemorrhage in the community: a closer look at the evidence.
    Oladapo OT.
    Int J Gynaecol Obstet; 2012 Nov 24; 119(2):105-10. PubMed ID: 22968139
    [Abstract] [Full Text] [Related]

  • 8. Initiating a novel therapy in preventing postpartum hemorrhage in rural India: a joint collaboration between the United States and India.
    Kodkany BS, Derman RJ, Goudar SS, Geller SE, Edlavitch SA, Naik VA, Patel A, Bellad MB, Patted SS.
    Int J Fertil Womens Med; 2004 Nov 24; 49(2):91-6. PubMed ID: 15188836
    [Abstract] [Full Text] [Related]

  • 9. Community-based distribution of misoprostol to prevent postpartum haemorrhage at home births: results from operations research in rural Ghana.
    Geller S, Carnahan L, Akosah E, Asare G, Agyemang R, Dickson R, Kapungu C, Owusu-Ansah L, Robinson N, Mensah-Homiah J.
    BJOG; 2014 Feb 24; 121(3):319-25. PubMed ID: 24283350
    [Abstract] [Full Text] [Related]

  • 10. Rectally administrated misoprostol as an alternative to intravenous oxytocin infusion for preventing post-partum hemorrhage after cesarean delivery.
    Chaudhuri P, Mandi S, Mazumdar A.
    J Obstet Gynaecol Res; 2014 Sep 24; 40(9):2023-30. PubMed ID: 25181622
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda.
    Lubinga SJ, Atukunda EC, Wasswa-Ssalongo G, Babigumira JB.
    PLoS One; 2015 Sep 24; 10(11):e0142550. PubMed ID: 26560140
    [Abstract] [Full Text] [Related]

  • 16. Recommendations for scale-up of community-based misoprostol distribution programs.
    Robinson N, Kapungu C, Carnahan L, Geller S.
    Int J Gynaecol Obstet; 2014 Jun 24; 125(3):285-8. PubMed ID: 24680582
    [Abstract] [Full Text] [Related]

  • 17. Comparative study between rectally administered misoprostol as a prophylaxis versus conventional intramuscular oxytocin in post partum hemorrhage.
    Haque N, Bilkis L, Haque N, Bari MS, Haque S.
    Mymensingh Med J; 2009 Jan 24; 18(1 Suppl):S40-44. PubMed ID: 19377430
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women.
    Chaudhuri P, Biswas J, Mandal A.
    Int J Gynaecol Obstet; 2012 Feb 24; 116(2):138-42. PubMed ID: 22100204
    [Abstract] [Full Text] [Related]

  • 20. Introducing misoprostol for the management of postpartum hemorrhage in Zimbabwe: final report on operational research.
    Zvandasara P, Chipato T, Mawere E, Rivelt K, McNally T.
    Cent Afr J Med; 2015 Feb 24; 61(9-12):76-83. PubMed ID: 29144067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.